A Seattle woman has died from a rare blood-clotting syndrome after receiving the Johnson & Johnson single dose COVID vaccine, health officials confirmed Tuesday. The 37-year-old woman was the first in ...

The FDA revised its emergency authorization to sharply limit the use of Johnson & Johnson's COVID-19 vaccine due to a rare but potentially fatal blood clotting condition called thrombosis with ...

When evaluating risks of thrombosis and thrombocytopenia individually across the various COVID-19 vaccines, there are some differences between the adenovirus- and mRNA-based shots, although risk of ...

A study published by The BMJ today sheds further light on the risk of developing a very rare blood-clotting condition known as thrombosis with thrombocytopenia syndrome (TTS) after vaccination against ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers noted a high mortality rate among patients ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio More than 50% of individuals with ...

Patients should be informed of a rare but serious clotting risk following vaccination with Johnson & Johnson’s single-dose COVID-19 jab, especially women under the age of 50, federal health ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Thrombosis with thrombocytopenia syndrome (TTS) — thrombocytopenia and increased bleeding risk ...

A new study has shed further light on the risk of developing the rare blood-clotting condition, thrombosis with thrombocytopenia syndrome (TTS), after vaccination against the COVID-19 virus. For their ...

Australia has limited use of the AstraZeneca COVID-19 vaccine to those 60 and over, recommending that younger adults receive the Pfizer-BioNTech jab instead amid instances of rare, severe blood clots.

A study published by The BMJ today sheds further light on the risk of developing a very rare blood-clotting condition known as thrombosis with thrombocytopenia syndrome (TTS) after vaccination against ...